Skip to content
Screener

Praxis Precision Medicines, Inc. PRAX Return on invested capital

Return on invested capital at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-6.1%-14.2pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-54%+2.2pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-114.4%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-52.1%+9.1pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
17.5%+5.1pp
Biogen logo
BiogenBIIB
4.6%-3.5pp

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083

FAQ

What is Praxis Precision Medicines, Inc.'s return on invested capital?
Praxis Precision Medicines, Inc. (PRAX) reported return on invested capital of -67.9% in Q2 2026.
How has Praxis Precision Medicines, Inc.'s return on invested capital changed year-over-year?
Praxis Precision Medicines, Inc.'s return on invested capital increased by 34.7% year-over-year, from -103.9% to -67.9%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about Praxis Precision Medicines, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude